News

Kirkland lures top Skadden corporate partner as talent war rages on

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Graham Robinson,

News

Editor's Top Picks

Elon Musk says he will spend a ‘lot less’ on politics

Unlock the White House Watch newsletter for freeYour guide to what Trump’s second term means for Washington, business and the

News

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form News

Hong Kong’s crypto push puts HSBC and StanChart in a bind

Receive free Cryptocurrencies updatesWe’ll send you a myFT Daily Digest email rounding up the latest

Before The Battery And Magnet: IRA And Mineral Supply Chains

The US Inflation Reduction Act (IRA) is designed to encourage investment throughout the supply chain

IMF warns central banks of ‘uncomfortable truth’ in inflation fight

Receive free Central banks updatesWe’ll send you a myFT Daily Digest email rounding up the

Energy Income Weekly: Energy Stocks Underperform But Return Prospects Are Bright

Energy Income Performance The energy sector got clobbered this week, as the S&P 500 (SP500)

Live news: Putin breaks silence after end of uprising

Russian president Vladimir Putin on Monday suggested Ukraine had somehow been involved in warlord Yevgeny

Forget The Fed And Load Up The Truck With Gold

Fundamentals The Federal Reserve has decided to maintain the current interest rates, pausing after a

Wagner chief hails march on Moscow as ‘masterclass’ but denies coup bid

The head of the Wagner militia has denied trying to overthrow the Russian government but

Amarin: New Management, But No Radical Changes To Strategy, Or Outlook (NASDAQ:AMRN)

In my previous article, we saw Sarissa taking over Amarin’s (NASDAQ:AMRN) management completely. The earlier

New York office market bolstered by sale valuing tower at $2bn

Receive free Commercial property updatesWe’ll send you a myFT Daily Digest email rounding up the

FibroGen’s Unsteady Course: Assessing Fallout From IPF Failure

Introduction FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company, specializes in connective tissue growth factor (CTGF) and

Guatemala heads for centre-left runoff as anger grows over corruption

Receive free Guatemala updatesWe’ll send you a myFT Daily Digest email rounding up the latest

adidas’s Strong Brand Will Likely Aid A Successful Recovery (OTCMKTS:ADDDF)

Introduction On September 19th, 2022 I published an adidas (OTCQX:ADDYY) article titled "It's Time To

Aston Martin aims to hit adjusted profit and revenue targets by 2024-25

Receive free Aston Martin Lagonda updatesWe’ll send you a myFT Daily Digest email rounding up

F5: Competitive And Profitable Despite Low Anticipated Growth (NASDAQ:FFIV)

F5's (NASDAQ:FFIV) share price is down by nearly 6% during the last three years, with

Goldman Sachs to name former trading boss Tom Montag for board seat

Receive free Goldman Sachs Group updatesWe’ll send you a myFT Daily Digest email rounding up